New Medication Shrinks Cancer in 80% of Patients
After using zanubrutinib, 80% of patients with a specific type of lymphoma had their tumors shrink in a clinical trial Lymphoma cancer is one of…
After using zanubrutinib, 80% of patients with a specific type of lymphoma had their tumors shrink in a clinical trial Lymphoma cancer is one of…
According to the researchers, the data indicate an urgent need for earlier endoscopic screening. Esophageal cancer is a type of cancer that develops in the…
New treatment can help regress congenital giant nevi. Skin cancer is the most common type of cancer in the United States. Every day, roughly 9,500…
University of Geneva scientists highlight the unexpected effect of certain immunotherapies to prevent cancer metastases. Tumors rely on a specific structure, the tumor stroma, to…
A trigger for ‘cell suicide’ might lead to new skin infection therapies Every second, one million cells in your body die. That means 2.6 pounds…
According to the Centers for Disease Control and Prevention, 41.9% of U.S. adults are obese, with 9.2% severely obese. Obesity contributes to a wide array…
According to a Rutgers University study, the cell receptor protein also stimulates the growth of brain cancer stem cells Stem cells are the body’s raw…
Research into a type of blood cancer called juvenile myelomonocytic leukemia suggests anti-inflammatory treatment as a possible new therapy for the disease Juvenile myelomonocytic leukemia…
Identifying DNA Repair Genes Holds Promise for Improving Cancer Treatment Cancer is one of the leading causes of death in the United States and worldwide….
Living near regions prone to wildfires may boost the risk of developing lung cancer and brain tumors. By looking at a population of nearly 2…
Smoking worsens the prognosis for men with prostate cancer According to a large population study led by Lund University in Sweden, smokers had a decreased…
While the United States spends twice as much on cancer care as the average high-income country, its cancer mortality rates are only slightly better than…
Findings from a seven-year research project suggests that there could be a new approach to treating one of the most common and devasting forms of…
Study shows combined IL-6 and immune checkpoint blockade reduces toxicity while preserving anti-tumor immune response The University of Texas MD Anderson Cancer Center researchers have…
The approach, studied in mice, overcomes the blood-brain barrier and breaks the shield tumors build against the immune response. When researchers at the University of…
Recurring brain tumor growth is halted with a new drug A patient’s options are limited when a non-metastatic brain tumor — a meningioma — recurs…
HKUMed develops a novel therapeutic approach against nasopharyngeal carcinoma by using exosomes derived from γδ-T cells synergized with radiotherapy A research team at LKS Faculty…
A new research study from the University of Southampton has discovered that ‘crown-like structures’ surrounding breast tumors in overweight and obese patients could hinder their…